title: Antibiotics for brain abscesses in people with cyanotic congenital heart disease.
abstract: BACKGROUND
  Brain abscess is a focal, intracerebral infection that begins as a localized area of brain infection and develops into a collection of pus surrounded by a well-vascularized capsule. People with cyanotic congenital heart disease are at risk of developing brain abscess.
  
  
  OBJECTIVE
  To evaluate the effectiveness of antibiotic regimens for treating brain abscess in people with cyanotic congenital heart disease.
  
  
  METHODS
  We updated the searches of the Cochrane Central Register of Controlled Trials (CENTRAL) on The Cochrane Library Issue 12 of 12, December 2012, MEDLINE Ovid (1946 to December Week 4 2012), EMBASE Ovid (1980 to 2013 Week 01) and LILACS (1980 to 9 January 2013) on 9 January 2013. No language or publication restrictions were applied.
  
  
  METHODS
  Randomized controlled trials that reported clinically meaningful outcomes and presented results on an intention to treat basis, irrespective of blinding, publication status, or language.
  
  
  METHODS
  Data were to be extracted, unblinded, by the two reviewers independently.
  
  
  RESULTS
  No studies meeting the inclusion criteria were identified.
  
  
  CONCLUSIONS
  There are no randomized controlled trials about the effectiveness of antibiotic regimens for treating people with cyanotic congenital heart disease who developed a brain abscess. Currently, the antibiotic regimens used are based on previous retrospective studies and clinical experience. There is a need for a well designed multicentre randomized controlled trial to evaluate the effects of different antibiotic regimens.
authors.affiliation: Department of Pediatrics, Faculty of Medicine, Khon Kaen, Thailand. paglum@kku.ac.th.
authors.forename: Pagakrong
authors.initials: P
authors.lastname: Lumbiganon
authors.forename: Arnkisa
authors.initials: A
authors.lastname: Chaikitpinyo
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001922:Brain Abscess / Q000188:drug therapy*; D003490:Cyanosis / Q000150:complications; D006330:Heart Defects, Congenital / Q000150:complications*; D006801:Humans
chemical_list: D000900:Anti-Bacterial Agents
references.citation: Indian J Pediatr. 1993 Jan-Feb;60(1):43-51
references.pmid: 8244485
references.citation: Antimicrob Agents Chemother. 1991 Dec;35(12):2606-10
references.pmid: 1810195
references.citation: Control Clin Trials. 1996 Feb;17(1):1-12
references.pmid: 8721797
references.citation: QJM. 2002 Aug;95(8):501-9
references.pmid: 12145389
references.citation: BMJ. 2001 Jul 7;323(7303):42-6
references.pmid: 11440947
references.citation: Neurosurgery. 1988 Oct;23(4):451-8
references.pmid: 3200375
references.citation: BMJ. 1997 Sep 13;315(7109):629-34
references.pmid: 9310563
references.citation: Clin Infect Dis. 1997 Oct;25(4):763-79; quiz 780-1
references.pmid: 9356788
references.citation: Ann Intern Med. 2001 Dec 4;135(11):982-9
references.pmid: 11730399
references.citation: Eur J Clin Microbiol Infect Dis. 2004 Jan;23(1):7-14
references.pmid: 14669073
references.citation: Childs Brain. 1983;10(4):251-65
references.pmid: 6884127
references.citation: Control Clin Trials. 1986 Sep;7(3):177-88
references.pmid: 3802833
references.citation: Pediatr Infect Dis. 1985 Jul-Aug;4(4):394-8
references.pmid: 4022805
references.citation: Pediatr Infect Dis J. 1989 Jul;8(7):449-58
references.pmid: 2666943
references.citation: Am J Cardiol. 1974 Jul;34(1):97-102
references.pmid: 4835759
references.citation: J Neurosurg. 1981 Nov;55(5):794-9
references.pmid: 7310502
references.citation: Clin Infect Dis. 1993 Nov;17(5):857-63
references.pmid: 8286626
references.citation: Stat Med. 1987 Apr-May;6(3):341-50
references.pmid: 3616287
references.citation: Ceylon Med J. 2003 Mar;48(1):14-6
references.pmid: 12795014
references.citation: JAMA. 1995 Feb 1;273(5):408-12
references.pmid: 7823387
references.citation: Neurosurgery. 1997 Dec;41(6):1270-8; discussion 1278-9
references.pmid: 9402578
references.citation: Rev Neurol. 1999 Sep 1-15;29(5):416-24
references.pmid: 10584243
references.citation: J Neurosurg. 1983 Jun;58(6):913-7
references.pmid: 6854384
references.citation: Neurosurgery. 1993 Jul;33(1):44-9
references.pmid: 8102792
references.citation: J Antimicrob Chemother. 1978 Sep;4(5):395-413
references.pmid: 357402
references.citation: Blood. 1987 Oct;70(4):1180-5
references.pmid: 3651603
references.citation: BMJ. 1994 Nov 12;309(6964):1286-91
references.pmid: 7718048
references.citation: J Clin Neurosci. 2001 Jan;8(1):18-22
references.pmid: 11322120
references.citation: Lancet. 1998 Aug 22;352(9128):609-13
references.pmid: 9746022
references.citation: Br J Neurosurg. 2000 Dec;14(6):525-30
references.pmid: 11272029
references.citation: Pediatrics. 1961 May;27:772-89
references.pmid: 13768201
references.citation: BMJ. 1999 Sep 11;319(7211):670-4
references.pmid: 10480822
references.citation: Ann Intern Med. 1975 Apr;82(4):571-6
references.pmid: 1168037